Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | PYGB | P11216 | 1/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | CD69 | Q07108 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2429112 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL8361874 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL5862474 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL17523750 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL5199795 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL3144958 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL229613 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL22026379 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL22047951 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL19603336 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5561119-A | ANTITUMOR AGENTS | LABORATOIRES HOECHST (FR) | 1996-10-01 | — | — | US | claimed |
| EP-2737057-B1 | NOVEL MARKERS FOR DOPAMINERGIC NEURON PROGENITOR CELLS | UNIV KYOTO (JP) | 2018-10-24 | — | — | EP | disclosed |
| US-9453840-B2 | Markers for dopaminergic neuron progenitor cells | KYOTO UNIVERSITY (JP) | 2016-09-27 | — | — | US | disclosed |
| US-20140193836-A1 | NOVEL MARKERS FOR DOPAMINERGIC NEURON PROGENITOR CELLS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2014-07-10 | — | — | US | disclosed |
| EP-2737057-A1 | NOVEL MARKERS FOR DOPAMINERGIC NEURON PROGENITOR CELLS | Kyoto University (JP) | 2014-06-04 | — | — | EP | disclosed |
| WO-2013015457-A1 | NOVEL MARKERS FOR DOPAMINERGIC NEURON PROGENITOR CELLS | KYOTO UNIVERSITY (JP) | 2013-01-31 | — | — | WO | disclosed |
| EP-0987296-B1 | A cellulosic composite product and a method of producing the same | CANON KK (JP) | 2006-12-20 | — | — | EP | disclosed |
| EP-1404691-A2 | METHOD FOR PRODUCING PERACYLATED 1-O-GLYCOSIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-04-07 | — | — | EP | disclosed |
| WO-2003006474-A2 | METHOD FOR PRODUCING PERACYLATED 1-O-GLYCOSIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-01-23 | — | — | WO | disclosed |
| US-6468668-B1 | MONOSACCHARIDE DERIVATIVE OR OLIGOSACCHARIDE DERIVATIVE IS REACTION PRODUCT WITH A DIACID, THIS IS REACTED WITH CELLULOSE; BIODEGRADABILITY, RECYCLING PROPERTIES, EXCELLENT MECHANICAL STRENGTH AND MOLD PROCESSABILITY | CANON KABUSHIKI KAISHA (JP) | 2002-10-22 | — | — | US | disclosed |
| EP-0987296-A1 | A cellulosic composite product and a method of producing the same | CANON KABUSHIKI KAISHA (JP) | 2000-03-22 | — | — | EP | disclosed |
| WO-1999050438-A2 | CHROMOGENIC INDOLE DERIVATIVES | INALCO S.P.A. (IT) | 1999-10-07 | — | — | WO | disclosed |
| EP-0938492-A1 | COMBINATORIAL SYNTHESIS OF CARBOHYDRATE LIBRARIES | SYNSORB Biotech Inc. (CA) | 1999-09-01 | — | — | EP | disclosed |
| WO-1998022487-A1 | COMBINATORIAL SYNTHESIS OF CARBOHYDRATE LIBRARIES | SYNSORB BIOTECH, INC. (CA) | 1998-05-28 | — | — | WO | disclosed |